Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Jonge

Showing results (101-110 of 479) with videos related to

Pageof 48
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: results of a pharmacokinetic studyJos J Kitzen, Christian Puozzo, Maja J de Jonge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Inter- and intrapatient variability in oral topotecan pharmacokinetics: implications for body-surface area dosage regimensW J Loos, H Gelderblom, A Sparreboom, et al.
Human Reproduction (Oxford, England)|October 1, 1991
Human sperm capacitation and the acrosome reactionL J Zaneveld, C J De Jonge, R A Anderson, et al.
Scandinavian Journal of Work, Environment & Health|September 19, 2001
Burnout and engagement at work as a function of demands and controlE Demerouti, A B Bakker, J de Jonge, et al.
Journal of Advanced Nursing|November 1, 2001
Well-being of intensive care nurses (WEBIC): a job analytic approachP M Le Blanc, J de Jonge, A E de Rijk, et al.
The Journal of Physical Chemistry. B|February 14, 2006
Controlling the energy transfer in dipole chainsJeroen J de Jonge, Mark A Ratner, Simon W de Leeuw, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|October 16, 2009
Integration of prospective and retrospective methods for risk analysis in hospitalsM Kessels-Habraken, T Van der Schaaf, J De Jonge, et al.
British Journal of Cancer|January 1, 1997
Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical developmentC J Gerrits, M J de Jonge, J H Schellens, et al.
Biophysical Journal|March 26, 2022
Following the tracks: How transcription factor binding dynamics control transcriptionWim J de Jonge, Heta P Patel, Joseph V W Meeussen, et al.
Clinical Pharmacology and Therapeutics|May 26, 1999
Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and salivaM J de Jonge, J Verweij, W J Loos, et al.
Pageof 48

Showing results (101-110 of 479) with videos related to

Sort By:
Pageof 48
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: results of a pharmacokinetic studyJos J Kitzen, Christian Puozzo, Maja J de Jonge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Inter- and intrapatient variability in oral topotecan pharmacokinetics: implications for body-surface area dosage regimensW J Loos, H Gelderblom, A Sparreboom, et al.
Human Reproduction (Oxford, England)|October 1, 1991
Human sperm capacitation and the acrosome reactionL J Zaneveld, C J De Jonge, R A Anderson, et al.
Scandinavian Journal of Work, Environment & Health|September 19, 2001
Burnout and engagement at work as a function of demands and controlE Demerouti, A B Bakker, J de Jonge, et al.
Journal of Advanced Nursing|November 1, 2001
Well-being of intensive care nurses (WEBIC): a job analytic approachP M Le Blanc, J de Jonge, A E de Rijk, et al.
The Journal of Physical Chemistry. B|February 14, 2006
Controlling the energy transfer in dipole chainsJeroen J de Jonge, Mark A Ratner, Simon W de Leeuw, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|October 16, 2009
Integration of prospective and retrospective methods for risk analysis in hospitalsM Kessels-Habraken, T Van der Schaaf, J De Jonge, et al.
British Journal of Cancer|January 1, 1997
Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical developmentC J Gerrits, M J de Jonge, J H Schellens, et al.
Biophysical Journal|March 26, 2022
Following the tracks: How transcription factor binding dynamics control transcriptionWim J de Jonge, Heta P Patel, Joseph V W Meeussen, et al.
Clinical Pharmacology and Therapeutics|May 26, 1999
Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and salivaM J de Jonge, J Verweij, W J Loos, et al.
Pageof 48